Synonyms CHP - Cutaneous hepatic porphyria, Constitutional porphyria, Cutaneous hepatic porphyria + [31] |
Introduction An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form. |
Target- |
Mechanism Magnetic resonance imaging enhancers |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date23 Dec 2022 |
Target |
Mechanism CD79B inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date10 Jun 2019 |
Target |
Mechanism NS5A inhibitors [+1] |
Active Org. |
Originator Org. |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date10 Oct 2014 |
Start Date01 May 2022 |
Sponsor / Collaborator [+3] |
Start Date20 Sep 2021 |
Sponsor / Collaborator |
Start Date21 Oct 2019 |
Sponsor / Collaborator |